Skip to content
Search

Latest Stories

Mental health leaders call for “comprehensive plan” to tackle growing demand

Leaders running mental health services have called for a comprehensive plan from the government to address the growing demand for mental healthcare in England.

Calling it a sober warning, the leaders said children and young people will have to face longer waits for their treatment absence of a concrete plan, leading to deterioration of their mental health.


Mental health leaders, such as NHS trust chief executives and medical directors have raised concerns that their services, workforce and patients are being sidelined while they face high demand and pressure, just like the rest of the NHS.

The NHS Confederation’s Mental Health Network has called for attention from the government and recovery plan to tackle the growing demand.

Matthew Taylor, chief executive of the NHS Confederation, said: “We are moving towards a new phase of needing to ‘live with’ coronavirus but for a worrying number of people, the virus is leaving a growing legacy of poor mental health that services are not equipped to deal with adequately at present.

“With projections showing that 10 million people in England, including 1.5 million children and teenagers, will need new or additional support for their mental health over the next three to five years it is no wonder that health leaders have dubbed this the second pandemic.

“A national crisis of this scale deserves targeted and sustained attention from the Government in the same way we have seen with the elective care backlog.”

Currently, around 1.6 million people are on the waiting list for specialised mental health treatment, and there are an additional eight million people who could benefit from this line sort of treatment.

The call follows the publication of the long-awaited NHS Elective Recovery Plan, which set out how the backlog of people needing planned surgical procedures will be addressed.

They noted that out of £44 billion of additional funding allocated for the NHS in the government’s Spending Review last year, none was specifically identified for mental health.

According to leaders’ estimate, mental health services would need an extra £1 billion in 2022/23 to keep up with the rising patient demand.

A recovery plan for mental healthcare should include provision of additional support for the mental health workers as they feel close to burnout.

It should also include expansion of estates for specialist mental healthcare, including modernizing dated buildings and equipment, as backed by the Royal College of Psychiatrists recently.

Moreover, new ways should be identified to encourage people to come forward and access support for their mental health.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less